Home / GENF.L : LSE

AI Analysis Fundamentals Video Analysis News Similar

AI Analysis

How does GENF.L make money? Does GENF.L have pricing power? What's the Earnings Whisper? Will GENF.L profit more as the business scales? What is GENF.L's management track record? Is GENF.L's current price justified?

Genflow Biosciences Plc

2.1p +$0.15 (+7.64%)

LSE · 16 Sep 2026 10:55 UTC

Previous Close

2.17p

Day Range

2.05p2.25p

Year Range

0.9p3.12p

Market Cap

11.89M

AVG Volume

1.48M

Trailing/Forward PE

-6.17/-

PEG ratio

0.08

Dividend Yield

Next Earnings Date

Primary Exchange

London Stock Exchange

Revenue (GBP)

GENF.L Revenue (GBP) by year
Period	Revenue (GBP)
2025	830.72K
2023	0
2022	0

Net Income (GBP)

GENF.L Net Income (GBP) by year
Period	Net Income (GBP)
2025	-1.42M
2023	-2.44M
2022	-2M

Operating Income (GBP)

GENF.L Operating Income (GBP) by year
Period	Operating Income (GBP)
2025	-1.42M
2023	-2.61M
2022	-2.49M

EBITDA (GBP)

GENF.L EBITDA (GBP) by year
Period	EBITDA (GBP)
2025	-1.42M
2023	-2.61M
2022	-1.82M

Cash Flows (GBP)

GENF.L Cash Flows (GBP) by year
Period	Cash Flows (GBP)
2025	-1.44M
2023	-2.49M
2022	-2.06M

EPS (GBP)

GENF.L EPS (GBP) by year
Period	EPS (GBP)
2025	-0
2023	-0.01
2022	-0.01

Expenses (GBP)

GENF.L Expenses (GBP) by year
Period	Expenses (GBP)
2025	2.18M
2023	3.12M
2022	3.1M

Cash & Debt (GBP)

GENF.L Cash & Debt (GBP) by year
Period	Cash & Debt (GBP)
2025	111.79K
2023	683.97K
2022	2.36M

Debt ratios

GENF.L Debt ratios by year
Period	Debt ratios
2025	0.11
2023	1.98
2022	9.39

Margins

GENF.L Margins by year
Period	Margins
2025	100%

Return on Capital

GENF.L Return on Capital by year
Period	Return on Capital
2025	257.37%
2023	-336.55%
2022	-84.64%

Shares Outstanding

GENF.L Shares Outstanding by year
Period	Shares Outstanding
2025	469.14M
2023	292.51M
2022	292.51M

Book Value Per Share (GBP)

GENF.L Book Value Per Share (GBP) by year
Period	Book Value Per Share (GBP)
2025	-0
2023	0
2022	0.01

Total Assets (GBP)

GENF.L Total Assets (GBP) by year
Period	Total Assets (GBP)
2025	452.39K
2023	1.07M
2022	2.62M

No video analysis for this stock yet. Request one from our team.

News: GENF.L

proactiveinvestors.com · 8 Sep 2026

Apple expected to unveil first foldable iPhone as new CEO Ternus takes stage

Apple Inc (NASDAQ:AAPL, XETRA:APC) is set to unveil its first foldable iPhone alongside a refreshed Pro lineup, in John Ternus's first major product launch...

proactiveinvestors.com · 4 Aug 2026

Caterpillar surges as AI demand drives record revenue

Caterpillar Inc (NYSE:CAT, XETRA:CAT) shares jumped 11% to $923 in pre-market trading on Tuesday after booming demand for power-generation equipment helped...

proactiveinvestors.com · 3 Aug 2026

Shell sells solar and wind operations to France's TotalEnergies

Shell PLC (LSE:SHEL, NYSE:SHEL) has struck a deal to sell its European onshore renewables business to France's TotalEnergies. The FTSE 100 oil giant said it...

proactiveinvestors.com · 3 Aug 2026

Dow Jones and Nasdaq climbs as big tech drive gains ahead of busy Wall Street week

Wall Street stocks opened the week firmly higher, as Microsoft and Amazon put some further Big Tech weight behind the rally that started last week. The Dow...

proactiveinvestors.com · 22 Jun 2026

Micron shares rise on Anthropic AI infrastructure partnership

Micron Technology Inc (NASDAQ:MU) shares rose more than 4% on Monday after the company announced a strategic agreement with Anthropic covering AI...

proactiveinvestors.com · 17 Jun 2026

Genflow to present beagle gene therapy data at longevity summit

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the longevity research company, has been invited to present results from its SLAB clinical study...